MK-7 Vitamin K-2 Extra Strength - 300 mcg

MK-7 Vitamin K-2 Extra Strength - 300 mcg

NOW4.8 (7,787 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 60 servings
Goals

Product analysis

95 out of 100

MK-7 Vitamin K-2 Extra Strength - 300 mcg offers a focused vitamin K supplement with clear labeling and favorable value. It may support bone and mineral functions when intake is low, though findings for bone density and arterial flexibility are limited and mixed.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality100

Vitamin K is provided as MK-7, a favorably regarded form. Its form alone does not establish superior everyday health outcomes.

Ingredient Transparency100

The vitamin K amount and MK-7 form are clearly identified. That makes it straightforward to compare with other vitamin K supplements.

Value For Money100

The MK-7 serving is competitively priced. Its clear single-ingredient formula makes the value comparison straightforward.

Customer Satisfaction92

Customer feedback is very positive. Thousands of ratings provide a broad view of buyer satisfaction.

Product Focus78

A single active ingredient keeps the formula focused on vitamin K. Bone and arterial findings are limited and mixed, so wider health expectations should remain modest.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.33
Customer rating
4.8 · 7,787 ratings
Report analysis

Goals

Bone Health
Impact
Highest effect
A Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Vitamin K · 300 mcg

MK-7 Vitamin K-2 Extra Strength - 300 mcg targets bone-protein activation, with limited support for maintaining bone density in postmenopausal women. Its 300 mcg of identified MK-7 supports the activation of proteins involved in bone mineralization. The higher amount is not evidence of a larger bone benefit.

Study evidence
Heart Health
Impact
High effect
B+ Ingredient FitD PathwaysB EvidenceA+ Formulation Logic
Vitamin K · 300 mcg

MK-7 Vitamin K-2 Extra Strength - 300 mcg has a narrow fit through limited support for arterial stiffness. Its 300 mcg vitamin K2 is explicitly identified as MenaQ7 MK-7, with no supported extra benefit from the higher amount.

Study evidence
Longevity
Impact
High effect
B+ Ingredient FitD PathwaysB EvidenceA+ Formulation Logic
Vitamin K · 300 mcg

MK-7 Vitamin K-2 Extra Strength - 300 mcg has a focused, narrow fit for arterial flexibility. The 300 mcg serving identifies MenaQ7, the preparation linked to selected arterial stiffness improvements in postmenopausal women. The higher amount does not imply a larger benefit.

Study evidence
Cardiovascular Support
Impact
High effect
A Ingredient FitC PathwaysC+ EvidenceA+ Formulation Logic
Vitamin K · 300 mcg

MK-7 Vitamin K-2 Extra Strength - 300 mcg offers focused, limited support for arterial flexibility. Its 300 mcg of vitamin K2 is explicitly identified as MK-7, the form linked to selected arterial-stiffness improvements. The higher amount does not imply a larger benefit.

Study evidence
Everyday Health
Impact
High effect
A Ingredient FitD+ PathwaysB EvidenceA+ Formulation Logic
Vitamin K · 300 mcg

MK-7 Vitamin K-2 Extra Strength - 300 mcg offers focused nutritional support when dietary intake falls short. Vitamin K at 300 mcg contributes to normal bone and mineral metabolism.

Study evidence

Ingredients

IngredientAmount per servingScore
Vitamin K2 (Menaquinone-7)
300 mcg 86
Gluten Free Adults 18–50 Vegan Dairy Free Vegetarian
Report overview
B+ Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyA+ Value
NOW MK-7 Vitamin K-2 Extra Strength - 300 mcg provides 300 mcg of vitamin K per serving as K2 as MK-7, with good value at $0.09 per 80 mcg of vitamin K, with $0.34 per serving. The amount is above a common maintenance level. The trans form is not specified.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  2. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  3. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  4. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  5. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  6. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  7. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  8. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  9. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  10. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  11. Dietary vitamin K intake associates with reduced all-cause mortality in non-alcoholic fatty liver disease patients.
    Huang Y; Zhu X; Han L; Hu H · Scientific reports · 2025
    Cohort study7,857 participantsEveryday Health forVitamin K
  12. Vitamin K status, cardiovascular disease, and all-cause mortality: a participant-level meta-analysis of 3 US cohorts.
    Shea MK; Barger K; Booth SL; Matuszek G; Cushman M; Benjamin EJ; Kritchevsky SB; Weiner DE · The American journal of clinical nutrition · 2020
    Meta-analysis3,891 participants3 studies pooledEveryday Health Longevity forVitamin K
  13. The Effect of Topical Vitamin K1 on the Treatment of Cetuximab-Induced Skin Rashes in Metastatic Colorectal Cancer Patients.
    Roayaei M; Rezaei M; Najafizade N · Advanced biomedical research · 2024
    Randomized trial49 participantsEveryday Health forVitamin K
  14. Effect of vitamin K on improving post‑kidney transplant outcomes: a meta‑analysis.
    Sun Z; Zhu K; Liang G; Yan F; Chao S; Jia L; Niu Y · Experimental and therapeutic medicine · 2023
    Meta-analysis7 studies pooledEveryday Health forVitamin K
  15. Vitamin K1 intake is associated with lower risk for all-cause and cardiovascular disease mortality in community-dwelling older Australian women.
    Dupuy M; Radavelli-Bagatini S; Zhong L; Dalla Via J; Zhu K; Blekkenhorst LC; Bondonno NP; Linneberg A; Bellinge JW; Schultz C; Courtney W; Prince RL; Hodgson JM; Lewis JR; Sim M · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2024
    Cohort study1,436 participantsEveryday Health forVitamin K
  16. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K
  17. Topical Menaquinone‑7 (Vitamin K2, MK-7) as a Mitochondrial Bioenergetic Activator for Skin Anti-Aging: Mechanistic Evidence in Skin Cells and a Randomized Split-Face/Neck Study.
    Huang H; Wei R; Xu C; Liu C; Zhao S; Li Y; Wang M · ACS omega · 2026
    Randomized trial30 participantsLongevity forVitamin K
  18. Vitamin K status and cognitive function in healthy older adults.
    Presse N; Belleville S; Gaudreau P; Greenwood CE; Kergoat MJ; Morais JA; Payette H; Shatenstein B; Ferland G · Neurobiology of aging · 2014
    Cross-sectional study320 participantsLongevity forVitamin K
  19. High dephospho-uncarboxylated matrix Gla protein concentrations, a plasma biomarker of vitamin K, in relation to frailty: the Longitudinal Aging Study Amsterdam.
    Machado-Fragua MD; Hoogendijk EO; Struijk EA; Rodriguez-Artalejo F; Lopez-Garcia E; Beulens JW; van Ballegooijen AJ · European journal of nutrition · 2021
    Cohort study644 participantsLongevity forVitamin K
  20. Vitamin K Concentration and Cognitive Status in Elderly Patients on Anticoagulant Therapy: A Pilot Study.
    Alisi L; Cafolla C; Gentili A; Tartaglione S; Curini R; Cafolla A · Journal of aging research · 2022
    Cross-sectional study85 participantsLongevity forVitamin K